U.S. Economic Recovery Quiets as July 4 Holiday Causes Dip in Shift Work

Following Waning June Recovery, Kronos U.S. Workforce Activity Report Reveals Rocky Shift Growth, Hiring in Early July LOWELL, Mass.–(BUSINESS WIRE)–#BusinessRecovery—Kronos: National Overview: In alignment with the national July 4 holiday observance, total volume of shifts worked1 decreased by 11.4% from June 29-July 5, mirroring – and, in fact, falling short of – the decline in … [Read more…]

Vizient’s Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of Propofol as COVID-19 Cases Surged

IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. announced that as cases of COVID-19 began surging in hotspots across the country in March and April, a novel supply program launched in January resulted in the availability of an additional 676,000 units of the sedative propofol, one of six drugs in the anesthetic and sedation class that may be used … [Read more…]

ImmunityBio & NantKwest Sign COVID-19 Joint Development, Manufacturing and Marketing Agreement; ImmunityBio Selected for ‘Operation Warp Speed’ to Develop Novel Adenovirus COVID-19 Vaccine 

ImmunityBio’s COVID-19 vaccine candidate was selected for Operation Warp Speed, a national program to accelerate COVID-19 vaccine development. Candidate is the first human adenovirus (Ad5) vaccine designed to deliver both Spike (S) and Nucleocapsid (N) DNA for potential long-lasting humoral and cell-mediated immunity NantKwest and ImmunityBio have signed a binding term sheet for the joint … [Read more…]

Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit

– Advanced Single Well Assay Designed for High-Throughput Testing – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #biotech–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company,” “our”) announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the clinical use of the Company’s patent-pending Linea™ COVID-19 RT-PCR test for … [Read more…]

Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit

– Kit offers same-day results to physician; Sensitivity to 1.25 copies of viral genome equates to less likely false negatives – – Spike protein and the corresponding gene links the diagnostic assay to the Company’s LinearDNA™ Vaccine Strategy – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #COVID19–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company,” “our”) … [Read more…]

Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

– Beyond expectations, a single injection of DNA in mice induced antibodies that block the infection of cultured human cells by SARS-CoV-2 – STONY BROOK, N.Y. & ROME–(BUSINESS WIRE)–#COVID19–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company” or “we/our”) today announced with its COVID-19 vaccine development partner Takis Biotech (“Takis”) that the first … [Read more…]

Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital

– Paves Path for Application to FDA for Emergency Use Authorization before end of April 2020 – – Company providing high-throughput RNA-extraction robotics and enhanced-sensitivity RT-qPCR assay with goals to diminish false negatives, quantify viral loads and enhance testing volumes for the region – STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #COVID19–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied … [Read more…]

Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing

– Preliminary Testing of Plasmid-based Vaccine Templates Shows Strong Immune Responses, Catalyzes Testing of Linear DNA-based Constructs Set to Begin Immediately – – RT-qPCR COVID-19 Diagnostic Gaining Promise – STONY BROOK, N.Y. & ROME–(BUSINESS WIRE)–$APDN #COVID19–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing … [Read more…]

 Celltrion Completes Neutralisation Test on Candidate Monoclonal Antibodies (mAbs) for COVID-19 Antiviral Antibody Treatment

 Celltrion completes selection of therapeutic antibodies which are most potent for neutralising the virus Celltrion expects cell-line development to commence this week Celltrion also plans to develop a super-antibody or an antibody cocktail therapy, to target potential mutations of SARS-CoV-2 INCHEON, Korea–(BUSINESS WIRE)–Celltrion Group today announced that the company has successfully selected the most potent … [Read more…]

CEL-SCI to Develop LEAPS COVID-19 Immunotherapy in Collaboration with University of Georgia Center for Vaccines and Immunology

Initial studies with COVID-19 corona virus aim to replicate prior successful preclinical experiments of LEAPS against H1N1pandemic flu in mice conducted with National Institutes for Allergies and Infectious Diseases (NIAID) Treatment targeted for patients who are at highest risk of dying from COVID-19 due to tissue damage from infection to the lungs Principal Investigator for … [Read more…]